CR2 Polyclonal Antibody, Cy5.5 Conjugated

Receptor for complement C3Dd, for the Epstein-Barr virus on human B-cells and T-cells and for HNRPU. Participates in B lymphocytes activation.

CR; C3DR; CD21; CVID7; SLEB9; Complement receptor type 2; Cr2; Complement C3d receptor; Epstein-Barr virus receptor; EBV receptor

1380

P20023

Cell membrane

Rabbit

Human, Rat

981-1092/1092

CR2

Polyclonal

IgG

Cy5.5

KLH conjugated synthetic peptide derived from human CR2

WB, FCM

Purified by Protein A.

675nm/694nm

1µg/µl

WB (1:300-5000), FCM (1:20-100)

Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Unmodified

Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

1380

Mouse